Data demonstrated a numerical treatment benefit across multiple efficacy measures, including full wound closure, despite study not being powered for statistical efficacy The study met its primary ...
BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - August 04, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
BOZEMAN, Mont. and VANCOUVER, BC, July 29, 2021 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, today announced that Mr. Robert A. Gillam, CFA, will be joining Microbion's Board of Directors as ...
BOZEMAN, Mont. and VANCOUVER, BC, Feb. 22, 2021 /PRNewswire/ — Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC (“Microbion”) today announced that it has received ...
Microbion Corporation, a clinical-stage pharmaceutical company developing a new class of therapeutic compounds to improve the lives of patients with rare and serious diseases, announced that the ...
BOZEMAN, MT and VANCOUVER, BC--(Marketwired - May 26, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that the U.S.
BOZEMAN, Mont. and VANCOUVER, British Columbia, Oct. 25, 2019 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced that the ...
BOZEMAN, MT and VANCOUVER, BC--(Marketwired - March 01, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that ...
Pravibismane is the first of a new class of drugs with broad-spectrum potency against a wide range of pathogens, including NTM species Poster presentation highlighted the results from pravibismane in ...
BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - June 16, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results